Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages

News

News

News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors

Welcome to epgonline.org - the website for healthcare professionals

What's new? The Bedwetting Knowledge Centre

Bedwetting, or nocturnal enuresis is defined as intermittent incontinence while sleeping. Applicable to children ≥ 5 years old, wetting episodes of any type that occur in discrete amounts are indicative to nocturnal enuresis.1,2

Due to variations in comorbidity, treatment response and pathogenesis, nocturnal enuresis can be divided into two subgroups – monosymptomatic nocturnal enuresis (MNE) and non-monosymptomatic nocturnal enuresis (NMNE).1,3 Absence of lower urinary tract symptoms or a history of bladder dysfunction is characteristic of MNE, while NMNE is defined as nocturnal enuresis accompanied by daytime urinary symptoms.

Nocturnal enuresis can have a profound impact on the child and their family, lowering a child’s self image, causing behavioural problems and affecting school performance. However, successful treatment improves the mental health of the child and brings practical relief to the family.

Latest News

FDA approves Tanzeum for use in Type 2 Diabetes-Glaxo Smith Kline

17-Apr-2014

The FDA has approved Tanzeum ...

BAX 111 completes successful Phase III trial for von Willebrand Disease- Baxter

17-Apr-2014

Baxter International Inc. announced ...

FDA approves Grastek for grass pollen-induced Allergic Rhinitis- Merck Inc.,

16-Apr-2014

Merck announced that the FDA has ...

Architect HbA1c test to diagnose Diabetes receives 510(k) approval in US- Abbott Diagnostics

16-Apr-2014

Abbott has announced that its new ...

Novartis announces job cuts

16-Apr-2014

Novartis intends to cut or shuffle up ...

FDA approves Revolution CT scanner for Imaging-GE HealthCare

15-Apr-2014

The FDA has given 510(k) clearance of ...

FDA approves the UltraShape System for Lipoplasty-Syneron Medical

15-Apr-2014

Syneron Medical has received FDA ...

Recent Updates

Drugs

Clinical Guidelines

Guidance for the pharmacological management of substance misuse among young people

ESC Guidelines for the diagnosis and treatment of pulmonary hypertension

ESPEN endorsed recommendations: Nutritional therapy in major burns

Guidelines on Urological Infections

Medical Journals

Poor Sensitivity of a Modified Alvarado Score in Adults With Suspected Appendicitis

Impairment of Lacrimal Secretion in the Unaffected Fellow Eye of Patients with Recurrent Unilateral Herpetic Keratitis

Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?

A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery

epgonline.org Social